Knowledge base · research

DSIP — an endogenous nonapeptide and research on circadian rhythm

DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide — a chain of nine amino acids (sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that mammalian organisms produce naturally. Like many signaling peptides, DSIP can be regarded as a fragment of the body's protein "language": a short message that nerve and endocrine cells are able to read. Its name derives from a historical observation — in pioneering experiments on animal models the compound was isolated in connection with slow-wave (delta) activity in the EEG recording. Since the 1970s DSIP has remained a subject of neuroendocrine research, primarily into the mechanisms of circadian rhythm. Scientifically, the most intriguing fact is that despite decades of research its exact molecular mechanism has still not been fully explained.

Mechanism in brief

The "lock and key" model assumes that a peptide fits a specific receptor like a key into a lock. In the case of DSIP the arrangement is atypical: to this day no single, specific receptor has been identified that would fully explain its action. In the preclinical literature DSIP is described as a molecule capable of crossing the blood-brain barrier and modulating various neurotransmitter systems as well as neuroendocrine axes (including the hypothalamic-pituitary axis). GABAergic signaling and an influence on clock genes regulating circadian rhythm are considered as potential pathways of action — however, these remain hypotheses requiring further verification.

What is being studied

The areas below are described in the preclinical literature. Each is assigned to a research model — these are not effects confirmed in humans.

  • Circadian rhythm. In animal models the role of DSIP in the neuroendocrine regulation of circadian rhythm was analyzed, along with its connection to slow-wave (delta) activity in the EEG recording.
  • Stress response / HPA axis. In animal models the influence of DSIP on the hypothalamic-pituitary-adrenal axis and on the levels of corticosteroid hormones associated with the stress reaction was studied.
  • Thermoregulation and neuromodulation. In vitro and in animal models the effect of DSIP on thermoregulatory processes and the modulation of nerve transmission was described.
  • Endocrine modulation. In preclinical studies the connections of DSIP with the secretion of pituitary hormones, including luteinizing hormone and somatotropin, were analyzed.

Origin and historical context

DSIP was isolated in the 1970s in Switzerland. Work by the team of Guido Schoenenberger and Marcel Monnier at the University of Bern led to the isolation of the peptide from the venous blood of the brain of rabbits subjected to electrical stimulation inducing characteristic slow-wave activity. The full name "Delta Sleep-Inducing Peptide" reflects this historical experimental context in which the compound was discovered, and not a confirmed application. Since then DSIP has been the subject of numerous works in the preclinical literature that attempted to establish its physiological role — not infrequently with ambiguous results.

Research specification

  • Form: lyophilisate (powder) intended for laboratory applications.
  • Storage (research context): the lyophilisate is usually stored at a low temperature, away from light and moisture; after reconstitution the laboratory standard is refrigeration and limiting the storage time.
  • Quality: the standard is determining purity by the HPLC method and verifying the identity of the molecule (e.g. mass spectrometry). These are elements of quality control of the research material, and not declarations concerning health.
  • Documentation: details regarding a given batch are found in the safety data sheets and the certificate of analysis (COA).

Level of evidence

Honestly: the overwhelming part of the knowledge about DSIP comes from in vitro studies and animal models. Data concerning humans are limited and ambiguous, and the absence of an identified specific receptor means that the mechanism of action remains a subject of scientific debate. Conclusions from the preclinical literature should not be automatically transferred to human physiology. The topic of DSIP requires further research, including better-controlled work clarifying its molecular targets.

For research purposes only. Not for consumption by humans or animals.

Frequently asked questions

Does DSIP have an identified receptor?
No. Despite decades of research, the preclinical literature has not described a single, specific receptor that would fully explain the action of DSIP. The peptide is able to cross the blood-brain barrier and is associated with the modulation of many systems, however its molecular target remains a subject of scientific debate and requires further research.
Where does the name "Delta Sleep-Inducing Peptide" come from?
The name is historical in character. In experiments on animal models from the 1970s (University of Bern) the compound was isolated in connection with slow-wave (delta) activity in the EEG recording. The name reflects this context of discovery, and not a confirmed application in humans.
Why is DSIP a peptide difficult to study via the oral route?
DSIP is a short chain of amino acids, susceptible to enzymatic breakdown in the gastrointestinal tract. For this reason, in the preclinical literature peptides of this type are analyzed in animal models and in vitro, bypassing the oral route, in order to preserve the integrity of the molecule and control its bioavailability in the experiment. This is solely a matter of research methodology in the model, and not information about use in humans.
How does DSIP differ from other neuropeptides in the literature?
DSIP is an endogenous nonapeptide, and its distinctiveness in the literature lies precisely in the absence of an identified specific receptor. It is studied mainly in the context of neuroendocrine regulation of circadian rhythm, the HPA axis and thermoregulation — in animal models and in vitro.
What is the level of scientific evidence for DSIP?
Mainly in vitro and animal models. Data concerning humans are limited and ambiguous, and the mechanism of action remains unexplained. Preclinical results do not automatically translate to human physiology and the topic requires further research.
For research purposes only. Not for human or animal consumption. This content is scientific and informational (mechanisms and research models) and is not medical advice or usage guidance.
View product → Build a research stack → Reconstitution calculator →

Related articles

ARA-290 (Cibinetide) — the tissue-repair receptor in research ARA-290 (cibinetide) is an erythropoietin-derived peptide studied as a selective innate repair receptor agonis Read → What are peptides? Classification, mechanism and receptors Peptides are short chains of amino acids studied in vitro and in animal models. Classification by receptor, th Read → How to Read a Certificate of Analysis (COA) for Research Peptides Research peptide Certificate of Analysis (COA): read HPLC purity, LAL endotoxin test, MS identification, batch Read → Thymosin Alpha-1 — a thymic peptide in immunological research Thymosin Alpha-1 — a 28-amino-acid thymic peptide studied in immunology: T cells, dendritic cells, TLR recepto Read →
Research newsletter
New research write-ups by email
No noise. Mechanisms, models and quality documentation — when something worthwhile appears.